Renalytix PLC
LSE:RENX

Watchlist Manager
Renalytix PLC Logo
Renalytix PLC
LSE:RENX
Watchlist
Price: 5.851 GBX -6.38% Market Closed
Market Cap: £25.6m

Relative Value

The Relative Value of one RENX stock under the Base Case scenario is hidden GBX. Compared to the current market price of 5.851 GBX, Renalytix PLC is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RENX Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

RENX Competitors Multiples
Renalytix PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Renalytix PLC
LSE:RENX
25.6m GBP 11.3 -1.7 -3.3 -3.3
US
Veeva Systems Inc
NYSE:VEEV
36.3B USD 11.8 42.2 31.9 33.3
US
Cerner Corp
LSE:0R00
31.3B USD 5.4 53.1 21.9 43.2
AU
Pro Medicus Ltd
ASX:PME
19.4B AUD 88 168.5 116.4 116.4
JP
M3 Inc
TSE:2413
1.3T JPY 3.9 28.4 14.4 17.7
US
Doximity Inc
NYSE:DOCS
7.4B USD 11.9 29.3 25.3 26.5
US
Waystar Holding Corp
NASDAQ:WAY
5B USD 4.8 45 15.2 23.8
SE
Sectra AB
STO:SECT B
43B SEK 19.6 68 -132.9 -132.9
CN
Winning Health Technology Group Co Ltd
SZSE:300253
25.6B CNY 11.8 -83.1 -164.3 -164.3
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
262.2B INR 10.3 56.3 34.6 40.4
US
Vocera Communications Inc
F:V00
2.4B EUR 11.9 -328 311.5 4 987.4
P/E Multiple
Earnings Growth PEG
UK
Renalytix PLC
LSE:RENX
Average P/E: 61.3
Negative Multiple: -1.7
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
42.2
32%
1.3
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
168.5
32%
5.3
JP
M3 Inc
TSE:2413
28.4
16%
1.8
US
Doximity Inc
NYSE:DOCS
29.3
18%
1.6
US
W
Waystar Holding Corp
NASDAQ:WAY
45
N/A N/A
SE
Sectra AB
STO:SECT B
68
17%
4
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -83.1
69%
N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
56.3
31%
1.8
US
V
Vocera Communications Inc
F:V00
Negative Multiple: -328 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
UK
Renalytix PLC
LSE:RENX
Average EV/EBITDA: 71.4
Negative Multiple: -3.3
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
31.9
38%
0.8
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
116.4
32%
3.6
JP
M3 Inc
TSE:2413
14.4
14%
1
US
Doximity Inc
NYSE:DOCS
25.3
23%
1.1
US
W
Waystar Holding Corp
NASDAQ:WAY
15.2
24%
0.6
SE
Sectra AB
STO:SECT B
Negative Multiple: -132.9 N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -164.3
36%
N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
34.6
24%
1.4
US
V
Vocera Communications Inc
F:V00
311.5
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
UK
Renalytix PLC
LSE:RENX
Average EV/EBIT: 661.1
Negative Multiple: -3.3
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
33.3
39%
0.9
US
C
Cerner Corp
LSE:0R00
43.2
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
116.4
31%
3.8
JP
M3 Inc
TSE:2413
17.7
N/A N/A
US
Doximity Inc
NYSE:DOCS
26.5
25%
1.1
US
W
Waystar Holding Corp
NASDAQ:WAY
23.8
58%
0.4
SE
Sectra AB
STO:SECT B
Negative Multiple: -132.9 N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -164.3
47%
N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
40.4
26%
1.6
US
V
Vocera Communications Inc
F:V00
4 987.4
N/A N/A